Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Tim Davies who wrote (3100)	8/20/2002 6:36:44 PM
From: SemiBull	Respond to of 10345

Elan Corporation, plc Contingent Value Rights -NASDAQ: LCVRZ- DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 20, 2002--Elan Corporation, plc (NYSE: ELN - News; "Elan") received a Nasdaq Staff Determination on August 12, 2002 indicating that the Company's Contingent Value Rights (Nasdaq: LCVRZ - News) issued as part of the consideration for the acquisition of The Liposome Company, Inc. in May 2000 are subject to delisting from The Nasdaq National Market at the opening of business on August 20, 2002 for non-compliance with the minimum number of market makers requirement set forth in Nasdaq Marketplace Rule 4450(a)(6). The Company has requested a hearing before a Nasdaq Listing Qualifications Panel to review the Staff Determination. The hearing request will stay the delisting of the Company's Contingent Value Rights pending the Panel's decision. There can be no assurance the Panel will grant the Company's request for continued listing. Elan is focused on the discovery, development, manufacturing, selling and marketing of novel therapeutic products in neurology, pain management and autoimmune diseases. Elan shares trade on the New York, London and Dublin Stock Exchanges. -------------------------------------------------------------------------------- Contact: Elan Corporation, plc Investors: (U.S.) Jack Howarth, 212-407-5740 or 800-252-3526 or Investors: (Europe) Emer Reynolds, 353-1-709-4000 or 00800 28352600 or Media: Sunny Uberoi, 212-322-4766